- Home
- FFIV vs SNN Comparison
FFIV vs SNN Comparison
Compare FFIV & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIV
- SNN
- Stock Information
- Founded
- FFIV 1996
- SNN 1856
- Country
- FFIV United States
- SNN United Kingdom
- Employees
- FFIV N/A
- SNN N/A
- Industry
- FFIV Computer Communications Equipment
- SNN Industrial Specialties
- Sector
- FFIV Telecommunications
- SNN Health Care
- Exchange
- FFIV Nasdaq
- SNN Nasdaq
- Market Cap
- FFIV 16.7B
- SNN 14.0B
- IPO Year
- FFIV 1999
- SNN 1999
- Fundamental
- Price
- FFIV $241.28
- SNN $33.44
- Analyst Decision
- FFIV Hold
- SNN Hold
- Analyst Count
- FFIV 11
- SNN 4
- Target Price
- FFIV $297.22
- SNN $32.83
- AVG Volume (30 Days)
- FFIV 1.2M
- SNN 570.8K
- Earning Date
- FFIV 10-27-2025
- SNN 10-30-2025
- Dividend Yield
- FFIV N/A
- SNN 2.19%
- EPS Growth
- FFIV 23.56
- SNN 59.91
- EPS
- FFIV 11.80
- SNN 0.56
- Revenue
- FFIV $3,088,072,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- FFIV $4.08
- SNN $7.85
- Revenue Next Year
- FFIV $3.95
- SNN $5.43
- P/E Ratio
- FFIV $20.43
- SNN $28.73
- Revenue Growth
- FFIV 9.66
- SNN 5.35
- 52 Week Low
- FFIV $223.76
- SNN $23.69
- 52 Week High
- FFIV $346.00
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- FFIV 39.41
- SNN 44.51
- Support Level
- FFIV $223.76
- SNN $31.95
- Resistance Level
- FFIV $243.77
- SNN $33.06
- Average True Range (ATR)
- FFIV 6.07
- SNN 0.49
- MACD
- FFIV 2.76
- SNN 0.01
- Stochastic Oscillator
- FFIV 73.04
- SNN 89.32
About FFIV F5 Inc.
F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.